MicroRNAs and cancer

T Dalmay

doi:10.1111/j.1365-2796.2008.01926.x

MicroRNAs and cancer

T Dalmay

Research output: Contribution to journal › Article › peer-review

119 Citations (Scopus)

Abstract

The Nobel Prize in Medicine and Physiology was awarded to the RNA interference (RNAi) field in 2006 because of the huge therapeutic potential this technique harbours. However, the RNAi technology is based on a natural mechanism that utilizes short noncoding RNA molecules (microRNAs) to regulate gene expression. This paper reviews our current knowledge about microRNAs focusing on their involvement in cancer and their potential as diagnostics and therapeutics.

Original language	English
Pages (from-to)	366-375
Number of pages	10
Journal	Journal of Internal Medicine
Volume	263
Issue number	4
DOIs	https://doi.org/10.1111/j.1365-2796.2008.01926.x
Publication status	Published - Apr 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1365-2796.2008.01926.x

Cite this

@article{5503c67d1a3c44298963cc1898a66192,

title = "MicroRNAs and cancer",

abstract = "The Nobel Prize in Medicine and Physiology was awarded to the RNA interference (RNAi) field in 2006 because of the huge therapeutic potential this technique harbours. However, the RNAi technology is based on a natural mechanism that utilizes short noncoding RNA molecules (microRNAs) to regulate gene expression. This paper reviews our current knowledge about microRNAs focusing on their involvement in cancer and their potential as diagnostics and therapeutics.",

author = "T Dalmay",

year = "2008",

month = apr,

doi = "10.1111/j.1365-2796.2008.01926.x",

language = "English",

volume = "263",

pages = "366--375",

journal = "Journal of Internal Medicine",

issn = "0954-6820",

publisher = "Wiley",

number = "4",

}

TY - JOUR

T1 - MicroRNAs and cancer

AU - Dalmay, T

PY - 2008/4

Y1 - 2008/4

N2 - The Nobel Prize in Medicine and Physiology was awarded to the RNA interference (RNAi) field in 2006 because of the huge therapeutic potential this technique harbours. However, the RNAi technology is based on a natural mechanism that utilizes short noncoding RNA molecules (microRNAs) to regulate gene expression. This paper reviews our current knowledge about microRNAs focusing on their involvement in cancer and their potential as diagnostics and therapeutics.

AB - The Nobel Prize in Medicine and Physiology was awarded to the RNA interference (RNAi) field in 2006 because of the huge therapeutic potential this technique harbours. However, the RNAi technology is based on a natural mechanism that utilizes short noncoding RNA molecules (microRNAs) to regulate gene expression. This paper reviews our current knowledge about microRNAs focusing on their involvement in cancer and their potential as diagnostics and therapeutics.

U2 - 10.1111/j.1365-2796.2008.01926.x

DO - 10.1111/j.1365-2796.2008.01926.x

M3 - Article

VL - 263

SP - 366

EP - 375

JO - Journal of Internal Medicine

JF - Journal of Internal Medicine

SN - 0954-6820

IS - 4

ER -